WHO Target Product Profiles for mpox Vaccines
16 October 2024
| Technical document
Overview
This document describes the preferred and minimally acceptable profiles for human vaccines for all clades of mpox. All vaccines considered for use must meet appropriate regulatory standards. In general, the minimally acceptable profiles are aligned with expectations for emergency use listing of new vaccines. Licensed or pre-qualified vaccines would likely have more of the attributes of the preferred profile.WHO Team
R&D Blue Print (RDB)